CDC-RFA-DD18-1803Publication.pdf

Centers for Disease Control

National Center on Birth Defects and Developmental Disabilities

Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders through National Professional Organizations

CDC-RFA-DD18-1803

Application Due Date: 06/13/2018

Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders through National Professional Organizations

CDC-RFA-DD18-1803

TABLE OF CONTENTS

Part I. Overview Information A. Federal Agency Name B. Funding Opportunity Title C. Announcement Type D. Agency Funding Opportunity Number E. Catalog of Federal Domestic Assistance (CFDA) Number F. Dates G. Executive Summary

Part II. Full Text A. Funding Opportunity Description B. Award Information C. Eligibility Information D. Application and Submission Information E. Review and Selection Process F. Award Administration Information G. Agency Contacts H. Other Information I. Glossary

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Send Me Change Notifications Emails" link to ensure they receive notifications of any changes to CDC-RFA-DD18-1803. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Reaching Healthcare Professionals in the Prevention of Fetal Alcohol Spectrum Disorders through National Professional Organizations C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https ://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

Amendment 1: Date for Informational Conference Call and Due Date for Applications have been changed. All changes are in red type.

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-DD18-1803

E. Catalog of Federal Domestic Assistance (CFDA) Number:

93.073 F. Dates:

1. Due Date for Letter of Intent (LOI): N/A

2. Due Date for Applications: 06/13/2018, 11:59 p.m. U.S. Eastern

Standard Time, at www.grants.gov.

Due date for applications has been amended to June 13, 2018.

3. Date for Informational Conference Call:

An informational call for potential applicants will take place April 27, 2018 at 2:00 p.m. U.S.

Eastern Time, Toll-Free: 855-644-0229, Conference ID: 4434827#.

G. Executive Summary:

1. Summary Paragraph:

The purpose of this NOFO is to promote prevention of fetal alcohol spectrum disorders (FASDs) through national medical societies and professional organizations with active health professional memberships relevant to settings serving pregnant women and women of reproductive age. Activities will include assessing and promoting member awareness of risky alcohol use, including any alcohol use during pregnancy, building/expanding champions networks to support awareness activities and dissemination of resources, development and https://www.grants.gov https://www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.grants.gov implementation of recertification requirements, promoting use of science-based messages, and clinical guidelines and policies that support implementation of alcohol screening and brief intervention (SBI). By the end of the project period recipients are expected to achieve the following short-term outcomes: increased knowledge about risky alcohol use, including any alcohol use during pregnancy, increased awareness of the importance of talking with patients about risky alcohol use, increased uptake of online courses, expanded champions networks, recertification requirements that include content related to alcohol/alcohol SBI/alcohol-exposed pregnancies, increased use of CDC communication products by members and patients, and increased use of alcohol SBI by members in their practice settings. Applicants must target one professional specialty—obstetrics and gynecology, nursing, family practice, social work, or medical assisting—on a national scale.

a. Eligible Applicants: Open Competition

b. NOFO Type: Cooperative Agreement

c. Approximate Number of Awards: 5

d. Total Period of Performance Funding: $5,000,000

e. Average One Year Award Amount: $250,000

f. Total Period of Performance Length: 4

g. Estimated Award Date: 08/30/2018

h. Cost Sharing and / or Matching Requirements: N Cost sharing or matching funds are not required for this program.

Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview Risky alcohol use can result in a wide range of negative health and social consequences and over time, can result in serious medical conditions, such as hypertension, liver disease, and various types of cancer. Prenatal alcohol exposure can result in fetal alcohol spectrum disorders in the developing baby and is associated with other poor birth outcomes, such as miscarriage, stillbirth, preterm birth, and sudden infant death syndrome. The term fetal alcohol spectrum disorders (FASDs) encompasses several diagnoses which represent a range of physical, mental, behavioral, and/or learning disabilities that can occur in an individual who was exposed to alcohol before birth. FASDs are the leading preventable cause of birth defects and developmental disabilities and are completely preventable if a baby is not exposed to alcohol in utero.

Although few estimates of the prevalence for the full range of FASDs are available, experts estimate that up to 1 in 20 U.S. school children might have FASDs. In addition, alcohol use among pregnant women continues to be a serious health concern. Recent data show that 10.2% of pregnant women report alcohol use and 3.1% of pregnant women report binge drinking in the past 30 days.

This NOFO is intended to increase healthcare professionals’ use of alcohol screening and brief intervention as a routine part of care, decrease risky alcohol use among women of reproductive age, including any alcohol use by pregnant women, and improve health outcomes, including those of women and their families.

Thus, this NOFO seeks to inform and educate members of national professional medical societies/organizations who work in primary care settings serving women, particularly pregnant women and women of reproductive age. These healthcare professionals are in a unique position to intervene with patients experiencing both acute and chronic health conditions caused or exacerbated by risky alcohol use. It is critical for healthcare professionals to understand how risky alcohol use affects their patients’ health, how to discuss risky alcohol use and its related harms with patients, and how to guide patients in reducing or stopping their risky use.

In 2014 CDC funded CDC-RFA-DD14-1403 Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships to provide training, emphasize primary prevention of FASDs and promote practice and system level changes among members of national medical professional societies/organizations.

This NOFO builds on these efforts to promote FASD prevention through national medical societies/professional organizations with active health professional memberships relevant to settings serving pregnant women and women of reproductive age.

b. Statutory Authorities This program is authorized under sections 301 [42 USC 241] and 317C of the Public Health Service Act, [42 U.S.C. Section 247b-4].

c. Healthy People 2020 This program addresses the Healthy People 2020 focus area of Maternal, Infant, and Child Healt

h. Relevant objectives include MICH-11.1, increase abstinence from alcohol among pregnant women from 89.4% to 98.3%; MICH-11.2, increase abstinence from binge drinking among pregnant women from 95% to 100%; MICH-16.4, increase the proportion of women delivering a live birth who did not drink alcohol prior to pregnancy from 51.3% to 56.4%; and MICH-25, reduce the occurrence of fetal alcohol syndrome (FAS).

d. Other National Public Health Priorities and Strategies https://www.healthypeople.gov/2020/topics-objectives/topic/maternal-infant-and-child-health/objectives https://www.healthypeople.gov/2020/topics-objectives/topic/maternal-infant-and-child-health/objectives

This NOFO supports the National Prevention Strategy – Strategic Direction: Clinical and Community Preventive Services; Priority Area: Preventing Drug Abuse and Excessive Alcohol Use https://www.surgeongeneral.gov/priorities/prevention/strategy/index.html#The Strategic Directions

e. Relevant Work CDC currently funds and works with medical societies and professional organizations (i.e.

American College of Obstetricians and Gynecologists; American Academy of Family Physicians; American Association of Medical Assistants; National Association of Nurse Practitioners in Women’s Health; American College of Nurse-Midwives; Association of Women’s Health, Obstetric and Neonatal Nurses; and National Association of Social Workers) under CDC-RFA-DD14-1403 Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships. These organizations have focused their work on issues involving alcohol education and medical practice, and prevention of alcohol-exposed pregnancies.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

Strategies and Activities

Short-term Outcomes

Long-Term Outcomes

Assess member knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy

Promote member awareness of risky alcohol use, including any alcohol use during pregnancy

Build/expand champions networks to support

Increased knowledge about risky alcohol use, including any alcohol use during pregnancy

Increased awareness of the importance of talking to patients about risky alcohol use, including any alcohol use during pregnancy

Increased uptake of online training courses

Healthcare professionals provide alcohol screening and brief intervention as a routine part of care

Decrease in risky alcohol use, including any alcohol use during pregnancy

Improved health outcomes, including health of women and their families awareness activities and dissemination of resources

Develop and implement re-certification requirements with content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies (AEP)

Promote use of science-based messages by members through testing and dissemination of CDC communication products

Promote clinical guidelines and policies that support implementation of alcohol

SBI

New/expanded champions networks

Recertification requirements include content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies (AEP)

Increased use of CDC communication products by members and patients

Increased use of alcohol SBI by members in their practice settings

i. Purpose

This NOFO promotes prevention of FASDs through national medical societies and professional organizations with active health professional memberships relevant to settings serving pregnant women and women of reproductive age. It will do this by promoting member awareness of risky alcohol use, including any alcohol use during pregnancy, building/expanding champion networks, developing and implementing recertification requirements, promoting use of science-based messages, and promoting clinical guidelines and policies that support implementation of alcohol screening and brief intervention.

ii. Outcomes By the end of this project period the recipients are expected to achieve all of the short-term outcomes as follows:

Increased knowledge about risky alcohol use, including any alcohol use during pregnancy

Increased awareness of the importance of talking to patients about risky alcohol use, including any alcohol use during pregnancy

Increased uptake of online training courses

New/expanded champions networks

Recertification requirements include content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies (AEP)

Increased use of CDC communication products by members and patients

Increased use of alcohol SBI by members in their practice settings

iii. Strategies and Activities The recipient is expected to implement the following strategies and activities during the project period.

Assess medical specialty/professional organization members' knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy o Assess members' knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy

Promote medical specialty/professional organization members' awareness of risky alcohol use, including any alcohol use during pregnancy o Expand the concept of alcohol as a medical issue (rather than solely as a behavioral/addiction issue) to healthcare professionals

Build/expand champions networks to support awareness activities and dissemination of resources o Develop and implement a plan for building or enhancing an existing champions network to support awareness activities and dissemination of resources

Develop and implement re-certification requirement with content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies

(AEP)

o Ensure recertification requirement includes the topic of risky alcohol use, including any alcohol use during pregnancy

Promote use of science-based messages by medical specialty/professional organization members through testing and dissemination of CDC communication products o Collaborate with CDC’s FAS program to pilot test newly developed CDC communication products o Collaborate with CDC’s FAS program to disseminate CDC communication products through organization’s membership and champions networks

Promote clinical guidelines and policies that support implementation of alcohol SBI o Promote alcohol screening and brief intervention (SBI) as an effective and low-cost clinical intervention aimed at reducing alcohol-exposed pregnancies and harms associated with risky alcohol use

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Recipient will collaborate with other CDC-funded FAS efforts including:

DD18-1801: Promoting Resources for Fetal Alcohol Spectrum Disorders Awareness and Prevention

DD18-1802: Implementing Alcohol Screening and Brief Intervention in Healthcare Systems Providing Women’s Health Services

b. With organizations not funded by CDC:

Applicants are encouraged to work with non-funded organizations who work with women of reproductive age, as appropriate.

Applicants who propose to work with a professional specialty outside their organizational structure should include a Memorandum of Agreement (MOA) from the professional specialty organization. The MOA should describe their history of working collaboratively to achieve similar outcomes and commitment to collaborate with the applicant to conduct the activities of this NOFO if funded. Applicants should name it "MOA", and upload it as a PDF file at www.grants.gov.

2. Target Populations Applicants must target one professional specialty—obstetrics and gynecology, nursing, family practice, social work, or medical assisting—on a national scale.

Achievement of the intended outcomes will benefit pregnant women and their families.

a. Health Disparities The applicant should consider providing information on how they will ensure that activities of this NOFO include diverse members of their professional specialty and those that work with underserved populations (i.e., people with disabilities, rural populations, tribal populations, sexual and gender minorities, non-English speaking populations, and people with limited health literacy skills).

iv. Funding Strategy

NA

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy The evaluation and performance measuring strategy will be used to assess the performance of the overall project and each recipient individually. Findings from the evaluation and performance strategy will encourage continuous program improvement and determine whether the program inputs are appropriate for achieving the desired outputs and outcomes, whether the program is effectively reaching the target audiences, and other methods of assessing program effectiveness. Evaluation findings and performance measures across recipient sites will be shared and disseminated by CDC.

Further details on program evaluation activities are described below. Included are examples of process measures that recipients should accomplish annually. CDC and recipients will have 6 months after award to discuss and finalize measures. These specific process measures are subject to change based on funding, number of recipients, and identified needs.

Strategy 1: Assess medical specialty/professional organization members' knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol during pregnancy.

Example process measures include:

Number and percentage of members included in assessments Measures of member knowledge, attitudes, practices, and training needs regarding risky alcohol use, including any alcohol use during pregnancy

Related Short-Term Outcomes:

Increased knowledge about risky alcohol use, including any alcohol use during pregnancy

Strategy 2: Promote medical specialty/professional members' awareness of risky alcohol use, including any alcohol use during pregnancy.

Example process measures include:

Documentation of a plan to promote member awareness of risky alcohol use, including any alcohol use during pregnancy, including promotion of the CDC Collaborative for Alcohol-Free Pregnancy online training courses found at www.cdc.gov/FASDTraining

Number of members completing online training courses Documentation of completion of activities in member organization promotion plan

Related Short-Term Outcomes:

Increased knowledge about risky alcohol use, including any alcohol use during pregnancy

Increased awareness of the importance of talking to patients about risky alcohol use, including any alcohol use during pregnancy http://www.cdc.gov/FASDTraining

Increased uptake of online training courses

Strategy 3: Build/expand champions networks to support awareness activities and dissemination of resources.

Example process measures include:

Number of champions networks Geographic location of champion networks Champion networks with a work plan to guide activities

Related Short-Term Outcomes:

New/expanded champions networks

Strategy 4: Develop and implement recertification requirements with content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies (AEP).

Example process measures include:

Documentation of content addressing risky alcohol use, including any alcohol use during pregnancy, in recertification requirements

Documentation of content addressing alcohol screening and brief intervention (SBI) in recertification content

Documentation of content addressing alcohol-exposed pregnancies (AEP) in recertification content

Related Short-Term Outcomes:

Recertification requirements include content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies (AEP).

Strategy 5: Promote use of science-based messages by members through testing and dissemination of CDC communication products.

Example process measures include:

Number of members participating in pilot testing of CDC communication products Number of CDC communication products disseminated through membership Documentation of members use of CDC communication products

Related Short-Term Outcomes:

Increased use of CDC communication products by members and patients

Strategy 6: Promote clinical guidelines and policies that support implementation of alcohol SBI.

Example process measures include:

Development of a plan to promote clinical guidelines and policies that support implementation of alcohol SBI

Implementation of a plan to promote clinical guidelines and policies that support implementation of alcohol SBI

Related Short-Term Outcomes:

Increased use of alcohol SBI by members in their practice settings

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans.

For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, within the first 6 months of award, as described in the Reporting Section of this NOFO.

https://www.cdc.gov/grants/additionalrequirements/ar-25.html

c. Organizational Capacity of Recipients to Implement the Approach The recipient should demonstrate experience and capacity to carry out the strategies and activities described within the notice of funding opportunity announcement. Specifically, the recipient should demonstrate their ability to:

Conduct the activities of the cooperative agreement, through documentation of previous relevant experience.

Identify and recruit qualified personnel, including credentials and appropriate experience to fill key positions and begin project activities in a timely fashion.

Describe all project staff, regardless of their funding source. Descriptions should include professional title, relevant qualifications and experience, percentage of time devoted to the project, as well as the portion of their salary to be paid by the cooperative agreement

Position descriptions for proposed project staff Identify adequate office space for the project.

Each applicant must identify and target only one of the professional specialties—obstetrics and gynecology, nursing, family practice, social work, or medical assisting. All applicants must either have the capacity to reach their selected specialty or must propose to work with one of these professional specialties outside of their organizational structure. To achieve national coverage, the organization should have regional or state offices or chapters and demonstrate how these chapters work together to reach members across the nation.

Applicants proposing to work with a professional specialty outside of their organizational structure as described in the Collaborations section, should refer to the professional specialty that your partner organization has within its mission the capacity to reach on a national basis.

Documentation of the organization’s mission statement, structure and its processes for ensuring that local, state and national members’ needs are addressed should be provided.

Applicants that represent the professional specialty they are aiming to reach should provide documentation of their organization’s mission statement, structure and its processes for ensuring local, state and national members’ needs are addressed.

All applicants must supply CVs/resumes of proposed staff and an overall organizational chart for their organization and other relevant organizations involved in the project. Applicants must name this file “CVs/Resumes” or “Organizational Charts” and upload it at www.grants.gov.

d. Work Plan The applicant should provide a detailed work plan for the first year of the project and a high-level work plan for the subsequent years.

Assess medical specialty/professional organization members' knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol http://www.grants.gov/ use during pregnancy.

o Conduct an assessment of members’ current knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy

Review existing, or develop new assessments of member knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy If assessments aren’t available or require updating, develop and implement a plan for assessing member knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy Document baseline measures to be used to assess changes in members’ knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy

Promote medical specialty/professional organization members' awareness of risky alcohol use, including any alcohol use during pregnancy.

o Expand the concept of alcohol as a medical issue (rather than solely as a behavioral/addiction one) to health care professionals

Based on the results of the assessment of member knowledge, attitudes, practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy, develop and implement a plan for promoting member awareness of risky alcohol use, including any alcohol use during pregnancy The plan should include the following at a minimum

Baseline measures of members' knowledge, attitudes, and practices, and training needs around the topic of risky alcohol use, including any alcohol use during pregnancy Strategies and activities, timelines, and responsible persons for reaching members, including through champions networks Plans for inclusion of members in the development and implementation of the plan Emphasize promotion and use of the CDC Collaborative for

Alcohol-Free Pregnancy online training courses found at www .cdc.gov/FASDtraining, and related resources Process measures for assessing the impact of the plan Number/percentage of members to be reached Expected outcomes

Build/expand champions networks to support awareness activities and dissemination of resources.

o Develop and implement a plan for building or enhancing an existing champions network to support awareness activities and dissemination of resources

Develop plans to assess the needs of a champions network if one exists, as well as application of lessons learned from similar past efforts Develop plans to develop a champions network if one does not currently exist At a minimum plans should http://www.cdc.gov/FASDtraining http://www.cdc.gov/FASDtraining

Ensure that new or existing champions networks have a national reach and include local, state and regional networks Describe strategies for engaging and communicating with members of champions networks Describe expected outcomes

Develop and implement re-certification requirement with content related to alcohol/alcohol screening and brief intervention (SBI)/alcohol-exposed pregnancies

(AEP).

o Review existing re-certification requirements around the topic of risky alcohol use, including any alcohol use during pregnancy

Develop and implement a plan for reviewing any existing recertification plan with content related to risky alcohol use, including any alcohol use during pregnancy, alcohol screening and brief intervention (SBI), and alcohol-exposed pregnancies

Plan should include the following, at a minimum Strategies and activities for inclusion of members in getting existing content updated or new content added Timelines and responsible persons Plans for ensuring that content is science-based and consistent with the purposes of this NOFO o If content related to risky alcohol use, including any alcohol use during pregnancy, is not included in existing re-certification requirements, develop and implement a plan for the inclusion of content

Plan should include the following, at a minimum Strategies and activities for inclusion of members in getting new content added Timelines and responsible persons Plans for ensuring that content is science-based and consistent with the purposes of this NOFO Promote use of science-based messages by members through testing and dissemination of CDC communication products.

o Collaborate with CDC’s FAS program to pilot test newly developed CDC communication products Identify a process for ensuring that members participate in pilot testing of newly developed CDC communication products o Collaborate with CDC’s FAS program to disseminate CDC communication products through organization’s membership and champions networks Describe plans to ensure dissemination of CDC communication products through the applicant organization’s membership and champion networks Plans should include the following, at a minimum

Strategies and activities to achieve the broadest reach possible among members Strategies and activities that include organization’s members Strategies and activities that include champion networks Plans to measure impact of dissemination activities

Timelines and responsible person(s) Promote clinical guidelines and policies that support implementation of alcohol SBI.

o Promote alcohol screening and brief intervention (SBI) as an effective and low-cost clinical intervention aimed at reducing alcohol-exposed pregnancies and harms associated with risky alcohol use

Describe any past or existing efforts to promote alcohol screening and brief intervention (SBI) with members and lessons learned from these efforts Develop and implement a plan to promote the use of alcohol screening and brief intervention (SBI) by members At a minimum, plans should

Build upon lessons learned from any existing or past efforts, or similar efforts Describe strategies to achieve the broadest reach possible among members Describe expected outcomes Include timelines and responsible persons Emphasize the use of CDC’s Planning and Implementing

Screening and Brief Intervention for Risky Alcohol Use: A Step-by-Step Guide for Primary Care Practices, USPSTF guidelines, screening instruments, etc.

o Develop and disseminate through membership clinical guidelines and policies on implementing alcohol SBI

Describe any past or existing efforts to promote clinical guidance and policies on alcohol screening and brief intervention (SBI) with members and lessons learned from these efforts Develop and implement a plan to promote the use of clinical guidance and policies on alcohol screening and brief intervention (SBI) by members Develop and implement a plan to support policy change within organizations through the development or revision of policy statements endorsing member adoption of alcohol SBI.

At a minimum, plans should

Build upon lessons learned from any existing or past efforts, or similar efforts Describe strategies to achieve the broadest reach possible among members Describe expected outcomes Include timelines and responsible persons Emphasize the use of CDC’s Planning and Implementing

Screening and Brief Intervention for Risky Alcohol Use: A Step-by-Step Guide for Primary Care Practices, USPSTF guidelines, screening instruments, etc.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

f. CDC Program Support to Recipients (THIS SECTION APPLIES ONLY TO

COOPERATIVE AGREEMENTS)

Technical assistance will be provided throughout the project period through the commitment of personnel and resources to provide subject matter expertise, and guidance on work plan development, program planning, capacity building, evaluation and performance measurement.

Information on practices, lessons learned, and evaluation results will be shared among recipients through a yearly grantee meeting, conference calls, and related activities.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism: U84 Cooperative Agreements for Fetal Alcohol Syndrome Prevention Research Programs

3. Fiscal Year: 2018

4. Approximate Total Fiscal Year Funding: $1,250,000

5. Approximate Period of Performance Funding: $5,000,000

This amount is subject to the availability of funds.

Estimated Total Funding: $5,000,000

6. Approximate Period of Performance Length: 4 year(s)

7. Expected Number of Awards: 5

8. Approximate Average Award: $250,000 Per Budget Period

9. Award Ceiling: $250,000 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: $200,000 Per Budget Period

11. Estimated Award Date: 08/30/2018

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Additional Eligibility Category:

2. Additional Information on Eligibility

The award ceiling for this NOFO is $ 250,000. CDC will consider any application requesting an award higher than this amount as nonresponsive and it will receive no further review.

3. Justification for Less than Maximum Competition

NA

4. Cost Sharing or Matching Cost Sharing / Matching Requirement: No Cost sharing or matching funds are not required for this program.

Although no statutory matching requirement for this NOFO exists, leveraging other resources and related ongoing efforts to promote sustainability is strongly encouraged.

5. Maintenance of Effort Maintenance of effort is not required for this program.

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number.

A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at www.SAM.gov.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the “Get Registered” option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do https://www.sam.gov/portal/public/SAM/ https://grants.gov/ https://www.grants.gov/ https://www.grants.gov/ https://www.grants.gov/ usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up 1 Data

Universal Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or call 1-866-705-5711

2 System for Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to www.sam.gov and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative (AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E- BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants

MUST

obtain a

DUNS

number and

SAM

account before applying on grants.gov)

Register early!

Log into grants.gov and check AOR status until it shows you have been approved http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://www.sam.gov https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this notice of funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488- 2700 or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.

4. Submission Dates and Times If the application is not submitted by the deadline published in the NOFO, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by

OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: N/A

b. Application Deadline Due Date for Applications: 06/13/2018 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Due date for applications has been amended to June 13, 2018.

Date for Information Conference Call An informational call for potential applicants will take place April 27, 2018 at 2:00 p.m. U.S.

Eastern Time, Toll-Free: 855-644-0229, Conference ID: 4434827#.

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ https://www.grants.gov https://www.grants.gov mailto:ogstims@cdc.gov https://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx

(S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Duplication of Efforts Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year.

Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source.

Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted.

Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.” The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent LOI is not requested or required as part of the application package for this NOFO.

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary (Maximum 1 page) A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov. The project abstract must be a self-contained, brief summary of the http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx https://www.grants.gov proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative (Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. This includes the work plan. Content beyond the specified page number will not be reviewed.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the following headings (including subheadings): Background, Approach, Applicant Evaluation and Performance Measurement Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities to be conducted over the entire period of performance as identified in the CDC Project Description section. Applicants should use the federal plain language guidelines and Clear Communication Index to respond to this Notice of Funding Opportunity. Note that recipients should also use these tools when creating public communication materials supported by this NOFO. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

ii. Outcomes Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description.

Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

iii. Strategies and Activities Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the period of performance outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies will be evaluated over the course of the project period.

See the Strategies and Activities section of the CDC Project Description.

1. Collaborations Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC. Applicants must address the Collaboration requirements as described in the CDC Project Description.

2. Target Populations and Health Disparities Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. The applicants must also address how they will include specific populations that can benefit from the program that is described in the Approach section.